At the SOTU, Biden said the Inflation Reduction Act is “taking on powerful interests to bring your healthcare costs down.” Absent from the speech was any mention of health insurers and PBMs. In the US, several stakeholders have created a system in whic…
Scientists have developed a robotic prosthetic that offers new hope of recovery for patients suffering from traumatic spinal injuries.
Advances in artificial intelligence antibody modeling may pave the way for more efficient antibody drug discovery in the near future.
Repeal and replace of the Inflation Reduction Act isn’t going to happen. But agencies such as CMS, tasked with carrying out the law, must interpret and administer the legislation. In so doing, the public (which includes drug makers) can provide CMS wit…
Researchers at the Leiden University Medical Center developed a “DNA medication pass” that connects a patient’s genetic profile to drugs of which it’s been shown that metabolic processing is influenced by DNA. Scanning the pass enables doctors to know …
Research suggests molnupiravir may supercharge new SARS-CoV-2 variants.
While ACE2 decoys have not worked against viruses in the past, can a receptor decoy work against the latest variants of SARS-CoV-2?
Amazon is adding RxPass to its pharmacy footprint. Purportedly, it’s competing with Mark Cuban’s Cost Plus Drug Company (MCCPDC). But, limitations suggest it isn’t yet a real competitor.
Researchers from the Brigham and Women’s Hospital tested a Trojan horse approach: using cancer cells to fight cancer itself.
Beginning on April 1, state Medicaid agencies will be able to unenroll people who signed up for coverage during the Covid-19 pandemic. The omnibus bill allows states to kick adults off of the Medicaid rolls, regardless of the status of the public healt…
